Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05334940 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Atopy Network - Comprehensive Allergy Centers: Medical Care of Patients With Moderate to Severe Allergic Diseases

Study acronym: ATAC
StatusUnknown
PhaseNot specified
Started2022-12-08
View on ClinicalTrials.gov ↗
Record status
This record was last updated August 21, 2024 (before its estimated August 31, 2025 completion). Its status may not reflect the trial's current state.

Amendment history

2026-09-06
Trial status changed: Recruiting → Unknown
2024-08-20
Study Status v3
Trial statusRecruiting→Unknown
2023-02-07
Study Status v2
Start dateestimated 2022-09-01→confirmed 2022-12-08
2022-07-19
Study Status v1
Primary completion date2025-04-01→2025-08-31
Completion date2025-04-01→2025-08-31
Start date2022-05-01→2022-09-01
2022-04-13
Original filing
The Atopy Registry aims to assess data about atopic disorders and their medical care in a standardized form. With this, the comparative efficacy, tolerability and safety of systemic therapies for atopic disorders should be investigated. An optional additional module "Bioanalytic" shall provide insights into further connections regarding immunology, genetics and microbiome.
Trial Details
NCT Number NCT05334940
Lead Sponsor Charite University, Berlin, Germany
Conditions Atopic Disorders
Enrollment 600 participants
Start Date 2022-12-08
Primary Completion 2025-08-31 (estimated)
Study Completion 2025-08-31 (estimated)
Updated on ClinicalTrials.gov 2024-08-21